The PICI Center at Weill Cornell Medicine performs discovery research to guide the development of new immunotherapeutic approaches that will be delivered by a diverse workforce to all populations. Recognizing the tremendous impact that immunotherapy can have in some cancers but also seeing the unmet clinical need in others, the PICI Center at WCM brings together basic scientists studying cancer cell biology with immunologists and T cell engineers to address these needs. This innovative, multi-disciplinary approach to deploying new therapies across a large, diverse catchment area is achieved through the collaboration of scientists and physician-scientists, community outreach professionals, veterinary oncologists and biomedical engineers. Jedd Wolchok, MD, PhD | Director Taha Merghoub, PhD | Co-Director All Investigators Related Point of View Guest Post: PICI Catalyzes Scientific Innovation Clinical Trial The AMADEUS Trial Clinical Trial The McGRAW Trial Clinical Trial The PRINCE Trial Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker Research Update Data to Design: Inside Our Spring Scientific Retreat Announcement, Our Impact, Press Release PICI at ASCO: New Data. Big Impact. Top Honors. Announcement, Partner Highlight, Press Release New PICI Collaboration Bolsters Science-to-Market Edge Announcement, Partner Highlight, Press Release PICI, Immunai to Build Landmark Cancer Dataset
Announcement, Partner Highlight, Press Release New PICI Collaboration Bolsters Science-to-Market Edge